CA2625279A1
(en)
*
|
1995-08-30 |
1997-03-06 |
Genzyme Corporation |
Chromatographic purification of adenovirus and aav
|
US20020088014A1
(en)
*
|
1996-05-31 |
2002-07-04 |
Xiangming Fang |
Minimal adenovirus mediated recombinant vaccine
|
US6485958B2
(en)
|
1996-07-01 |
2002-11-26 |
Gencell Sa |
Method for producing recombinant adenovirus
|
US7732129B1
(en)
*
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
WO1998022588A2
(en)
|
1996-11-20 |
1998-05-28 |
Introgen Therapeutics, Inc. |
An improved method for the production and purification of adenoviral vectors
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
US6989264B2
(en)
*
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
CA2307016A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Recombinational cloning using nucleic acids having recombination sites
|
US7705602B2
(en)
*
|
1997-11-03 |
2010-04-27 |
Midtronics, Inc. |
Automotive vehicle electrical system diagnostic device
|
US20040204381A1
(en)
*
|
1997-11-12 |
2004-10-14 |
Moskal Joseph R |
Detection and treatment of glyco-enzyme-related disease
|
US6899870B1
(en)
*
|
1998-03-11 |
2005-05-31 |
Board Of Regents, The University Of Texas System |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
|
CA2328462C
(en)
*
|
1998-04-22 |
2010-11-09 |
Genvec, Inc. |
Efficient purification of adenovirus
|
US6416992B1
(en)
*
|
1998-10-13 |
2002-07-09 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
US7691370B2
(en)
*
|
1998-10-15 |
2010-04-06 |
Canji, Inc. |
Selectivity replicating viral vector
|
ES2323991T3
(es)
*
|
1998-11-16 |
2009-07-28 |
Introgen Therapeutics, Inc. |
Formulacion de adenovirus para terapia genica.
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
US7148035B1
(en)
*
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
US6210922B1
(en)
*
|
1998-11-30 |
2001-04-03 |
National Research Council Of Canada |
Serum free production of recombinant proteins and adenoviral vectors
|
NZ512504A
(en)
|
1998-12-31 |
2004-01-30 |
Aventis Pharma Sa |
Method for separating viral particles
|
FR2788064B1
(fr)
*
|
1998-12-31 |
2003-01-31 |
Aventis Pharma Sa |
Methode de separation de particules virales
|
DE60029195T2
(de)
|
1999-02-22 |
2007-06-28 |
Transgene S.A. |
Verfahren zur Gewinnung von purifizierter Virenzusammensetzung
|
US6795585B1
(en)
|
1999-07-16 |
2004-09-21 |
Eastman Kodak Company |
Representing digital images in a plurality of image processing states
|
AU2911501A
(en)
*
|
1999-12-29 |
2001-07-09 |
Genzyme Corporation |
Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants
|
US6168941B1
(en)
*
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
JP2004509065A
(ja)
*
|
2000-04-28 |
2004-03-25 |
ゼンジェン インコーポレイテッド |
α−MSHおよびその誘導体を用いる遺伝子治療システムおよび方法
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
TWI289158B
(en)
*
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
US20020064860A1
(en)
*
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
CA2437962C
(en)
*
|
2001-03-16 |
2005-11-15 |
Oncolytics Biotech Inc. |
Method of extracting virus from cell culture
|
US20040146590A1
(en)
*
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
US7879606B2
(en)
*
|
2001-03-27 |
2011-02-01 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods useful for HCV infection
|
CA2455499C
(en)
|
2001-08-08 |
2011-06-21 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
US20040253210A1
(en)
*
|
2001-08-30 |
2004-12-16 |
Marjorie Robert-Guroff |
Adenovirus type7 vectors
|
DE60233061D1
(de)
*
|
2001-09-06 |
2009-09-03 |
Alphavax Inc |
Alphavirus replikon-vektorsysteme
|
WO2003039459A2
(en)
*
|
2001-11-05 |
2003-05-15 |
Genvec, Inc. |
Viral vector production methods and compositions
|
EP1407006B9
(de)
*
|
2001-12-20 |
2006-10-18 |
Bavarian Nordic A/S |
Methode zur gewinnung und reinigung von poxviren aus infizierten zellen
|
KR100451308B1
(ko)
*
|
2001-12-28 |
2004-10-06 |
선바이오(주) |
단백질 의약품 정제 방법에서의 바이러스 제거 방법
|
WO2003068163A2
(en)
*
|
2002-02-14 |
2003-08-21 |
Novavax, Inc. |
Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
|
DE60304836T2
(de)
*
|
2002-02-20 |
2006-11-30 |
Merck & Co., Inc. |
Verfahren zur konzentrationsbestimmung von adenoviruspartikeln
|
US20030180936A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Memarzadeh Bahram Eric |
Method for the purification, production and formulation of oncolytic adenoviruses
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
US20030186832A1
(en)
*
|
2002-03-15 |
2003-10-02 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Isotropic liquid detergents with improved anti-redeposition
|
WO2003084479A2
(en)
*
|
2002-03-29 |
2003-10-16 |
Merck & Co., Inc. |
Large scale methods of producing adenovirus and adenovirus seed stocks
|
WO2003093463A1
(en)
*
|
2002-04-30 |
2003-11-13 |
Oncolytics Biotech Inc. |
Improved viral purification methods
|
EP1783212B1
(de)
|
2002-05-14 |
2011-01-05 |
Merck Sharp & Dohme Corp. |
Verfahren zur reinigung von adenovirus
|
US20030224354A1
(en)
*
|
2002-05-30 |
2003-12-04 |
Introgen Therapeutics Inc. |
Quantifying viral particles with intrinsic fluorescence
|
EP1371723A1
(de)
*
|
2002-06-12 |
2003-12-17 |
Procorde GmbH |
Verfahren zur Herstellung von einer Adenoviruszubereitung
|
US20040219516A1
(en)
*
|
2002-07-18 |
2004-11-04 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
WO2004020971A2
(en)
*
|
2002-08-28 |
2004-03-11 |
Introgen Therapeutics Inc. |
Chromatographic methods for adenovirus purification
|
AU2003282726B2
(en)
*
|
2002-10-03 |
2010-10-07 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
EP1558748A4
(de)
*
|
2002-11-01 |
2008-10-22 |
Promega Corp |
Zellysezusammensetzungen, verwendungsverfahren, vorrichtung und kit
|
EP1590451B1
(de)
*
|
2002-12-13 |
2015-09-16 |
Alphavax, Inc. |
Alphaviruspartikel und herstellungsverfahren
|
EP1585812B1
(de)
*
|
2002-12-13 |
2017-01-18 |
Alphavax, Inc. |
Multiantigene alphavirusrepliconpartikel und verfahren
|
JP2006516548A
(ja)
|
2002-12-30 |
2006-07-06 |
アンジオテック インターナショナル アクツィエン ゲゼルシャフト |
迅速ゲル化ポリマー組成物からの薬物送達法
|
WO2004064785A2
(en)
|
2003-01-14 |
2004-08-05 |
Dana Farber Cancer Institute |
Cancer therapy sensitizer
|
CN1791678A
(zh)
*
|
2003-03-20 |
2006-06-21 |
阿尔法瓦克斯公司 |
改进的甲病毒复制子和辅助构建体
|
EP1620549B1
(de)
*
|
2003-05-01 |
2007-08-22 |
DSM IP Assets B.V. |
Verfahren zur herstellung von biologischen substanzen durch perfusionskultivierung von suspendierten tierischen zellen
|
US20040229335A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Introgen Therapeutics, Inc. |
Methods and compositions for the production of adenoviral vectors
|
EP1633321A4
(de)
*
|
2003-06-18 |
2006-11-02 |
Onyx Pharma Inc |
Verfahren zur reinigung von virus
|
DE602004021260D1
(de)
*
|
2003-07-11 |
2009-07-09 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
CA2531773A1
(en)
|
2003-07-21 |
2005-02-17 |
Transgene S.A. |
Novel multifunctional cytokines
|
DE602004027538D1
(de)
*
|
2003-12-01 |
2010-07-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
US20050153419A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Schering Corporation |
Methods for producing cell lines stable in serum-free medium suspension culture
|
US20070207461A1
(en)
*
|
2004-02-23 |
2007-09-06 |
Crucell Holland B.V. |
Virus Purification Methods
|
CN100333797C
(zh)
*
|
2005-01-26 |
2007-08-29 |
彭朝晖 |
重组腺病毒p53制品在肿瘤治疗中的新用途
|
CA2567574C
(en)
|
2004-04-08 |
2013-01-08 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
ES2321212T3
(es)
|
2004-05-18 |
2009-06-03 |
Alphavax, Inc. |
Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
|
ES2932278T3
(es)
*
|
2004-06-01 |
2023-01-17 |
Genzyme Corp |
Composiciones y métodos para prevenir la agregación del vector AAV
|
US20050287616A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Gross Adam F |
Method of assaying denaturation of proteins
|
EP2532653A1
(de)
|
2004-08-25 |
2012-12-12 |
Targegen, Inc. |
Benzo[1,2,4]triazine als Proteinkinasemodulatoren
|
DE202004014949U1
(de)
*
|
2004-09-25 |
2004-11-18 |
Techno-Grafica Gmbh |
Vorrichtung zum Wärmebehandeln einer Beschichtung von Flachoffset-Druckplatten
|
DE102004049290A1
(de)
*
|
2004-10-09 |
2006-04-20 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Virusmaterial
|
US7901921B2
(en)
*
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
EP1815029A4
(de)
*
|
2004-11-03 |
2009-06-10 |
Introgen Therapeutics Inc |
Neues verfahren zur herstellung und reinigung von adenovirusvektoren
|
CN100497640C
(zh)
*
|
2004-11-26 |
2009-06-10 |
中国人民解放军军事医学科学院生物工程研究所 |
一种高效生产重组腺病毒载体的方法
|
US20060166364A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Introgen, Inc. |
Use of flexible bag containers for viral production
|
EP1831353B1
(de)
*
|
2004-12-23 |
2012-02-29 |
MedImmune, LLC |
Nichttumorbildende mdck-zellinie zur vermehrung von viren
|
US20060205080A1
(en)
*
|
2005-03-01 |
2006-09-14 |
David Frey |
Formulations for therapeutic viruses having enhanced storage stability
|
JP5225069B2
(ja)
|
2005-03-23 |
2013-07-03 |
ゲンマブ エー/エス |
多発性骨髄腫の治療のためのcd38に対する抗体
|
DE602006003420D1
(de)
*
|
2005-04-11 |
2008-12-11 |
Crucell Holland Bv |
Virusreinigung mit ultrafiltration
|
WO2006121803A1
(en)
*
|
2005-05-05 |
2006-11-16 |
Sensient Flavors Inc. |
Production of beta-glucans and mannans
|
JP2008543775A
(ja)
*
|
2005-06-08 |
2008-12-04 |
ターゲジェン インコーポレーティッド |
眼の障害を治療するための方法および組成物
|
US20090216452A1
(en)
*
|
2005-07-05 |
2009-08-27 |
Develop Tech Resources |
Energy recovery within a fluid distribution network using geographic information
|
EP1951684B1
(de)
*
|
2005-11-01 |
2016-07-13 |
TargeGen, Inc. |
Biarylmetapyrimidinkinaseinhibitoren
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
CA2646391A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Viral Logic Systems Technology Corp. |
Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
|
WO2007127366A2
(en)
*
|
2006-04-25 |
2007-11-08 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
EP2069480B1
(de)
*
|
2006-09-15 |
2014-03-19 |
MedImmune, LLC |
Mdck-zelllinien zur unterstützung von virenwachstum auf hohe konzentrationen und bioreaktorverfahren damit
|
MX2009008118A
(es)
|
2007-01-30 |
2009-10-13 |
Transgene Sa |
Polipeptido e2 del virus del papiloma usado para vacunacion.
|
US20080299624A1
(en)
*
|
2007-06-01 |
2008-12-04 |
Edward Heslop |
Continuous fermentation apparatus and method
|
WO2008156829A2
(en)
*
|
2007-06-21 |
2008-12-24 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
EP2674483B1
(de)
*
|
2007-10-08 |
2017-05-03 |
Intrexon Corporation |
Manipulierte dendritische Zellen und Verwendungen zur Behandlung von Krebs
|
AU2008319053B2
(en)
|
2007-11-01 |
2012-04-26 |
Astellas Pharma Inc. |
Immunosuppressive polypeptides and nucleic acids
|
US20090253184A1
(en)
*
|
2008-01-23 |
2009-10-08 |
Introgen Therapeutics, Inc. |
Compositions and methods related to an adenoviral trans-complementing cell line
|
US10316352B2
(en)
*
|
2008-05-13 |
2019-06-11 |
Gen-Probe Incorporated |
Methods of capturing a target nucleic acid for amplification and detection using an inactivatable target capture oligomer
|
US9169491B2
(en)
*
|
2008-06-18 |
2015-10-27 |
Oxford Biomedica (Uk) Limited |
Virus purification
|
KR20110074564A
(ko)
*
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
세포 배양, 바이러스 증식 및 바이러스 정제를 위한 방법
|
AU2009296628B2
(en)
|
2008-09-24 |
2015-01-15 |
Medimmune, Llc |
Methods for purification of viruses
|
WO2010062757A1
(en)
*
|
2008-11-03 |
2010-06-03 |
Ligocyte Pharmaceuticals, Inc. |
Improved methods for isolating enveloped virus-based vlps free of infectious agents
|
WO2010060719A1
(en)
|
2008-11-03 |
2010-06-03 |
Crucell Holland B.V. |
Method for the production of adenoviral vectors
|
US9523344B2
(en)
*
|
2009-05-26 |
2016-12-20 |
Leviathan Energy Hydroelectric Ltd. |
Hydroelectric in-pipe turbine uses
|
CN103398936A
(zh)
*
|
2009-07-07 |
2013-11-20 |
索尼公司 |
微流体装置
|
KR20120052352A
(ko)
|
2009-08-07 |
2012-05-23 |
트랜스진 에스.에이. |
Hbv 감염을 치료하는 조성물
|
DK2488635T3
(en)
|
2009-10-15 |
2014-02-24 |
Crucell Holland Bv |
A method for purifying adenovirus of cultures with high cell density
|
KR101749779B1
(ko)
|
2009-10-15 |
2017-06-21 |
크루셀 홀란드 비.브이. |
아데노바이러스 입자의 정제 방법
|
SG10201500048SA
(en)
|
2010-01-05 |
2015-03-30 |
Vascular Biogenics Ltd |
Compositions and methods for treating glioblastoma gbm
|
EP3159405B8
(de)
|
2010-01-05 |
2018-11-07 |
Vascular Biogenics Ltd. |
Verfahren zur verwendung eines spezifischen adenovirenmittels gegen angiogenese
|
EP2523681A1
(de)
*
|
2010-01-12 |
2012-11-21 |
Vascular Biogenics Ltd. |
Verfahren zur herstellung von adenovirusvektoren und damit hergestellte virale zubereitungen
|
WO2011098592A1
(en)
|
2010-02-15 |
2011-08-18 |
Crucell Holland B.V. |
Method for the production of ad26 adenoviral vectors
|
CN102985536B
(zh)
|
2010-04-14 |
2017-12-05 |
Emd密理博公司 |
生产高效价、高纯度的病毒母液的方法及使用其的方法
|
CN103052399B
(zh)
|
2010-08-12 |
2016-06-29 |
依生生物制药控股有限公司 |
用于减少病毒组合物中dna杂质的方法
|
AP3390A
(en)
|
2010-09-20 |
2015-08-31 |
Crucell Holland Bv |
Therapeutic vaccination against active tuberculosis
|
CA2809463C
(en)
|
2010-09-27 |
2021-05-25 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
US8892184B2
(en)
|
2010-10-18 |
2014-11-18 |
Siemens Medical Solutions Usa, Inc. |
Systems and methods for reducing interference in a dual modality imaging system
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
EP2461162A1
(de)
|
2010-12-03 |
2012-06-06 |
Texcell, . |
Verfahren zur Bestimmung des Titers von Viren durch Verwendung von infektiösen Standardsubstanzen
|
JP5940554B2
(ja)
|
2010-12-09 |
2016-06-29 |
アンスティテュ・パストゥールInstitut Pasteur |
高収量の組換えタンパク質発現を得るためのmgmtに基づく方法
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Hbv聚合酶突變體
|
US10046417B2
(en)
|
2011-08-17 |
2018-08-14 |
Honeywell International Inc. |
Lead-free solder compositions
|
TW201321016A
(zh)
|
2011-09-29 |
2013-06-01 |
Transgene Sa |
免疫療法組成物及用於治療c型肝炎病毒感染之療程(二)
|
TW201318637A
(zh)
|
2011-09-29 |
2013-05-16 |
Transgene Sa |
免疫療法組成物及用於治療c型肝炎病毒感染之療程(一)
|
US20130122038A1
(en)
|
2011-11-14 |
2013-05-16 |
The United States Of America As Represented By The Secretary Of The Department |
Heterologous prime-boost immunization using measles virus-based vaccines
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
JP5770952B2
(ja)
|
2012-03-12 |
2015-08-26 |
クルセル ホランド ベー ヴェー |
改変末端を有する組換えアデノウイルスのバッチ
|
BR112014023196B1
(pt)
|
2012-03-22 |
2021-09-08 |
Janssen Vaccines & Prevention B.V. |
Vacinas contra o vírus sincicial respiratório (rsv), seu método de produção, e ácido nucleico recombinante isolado
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
DK2877601T3
(da)
*
|
2012-07-26 |
2019-08-05 |
Flash Therapeutics |
Fremgangsmåde til detektering eller måling af virkningen af en virusvektor-sammensætning på eukaryotiske celler og biomarkører
|
EP2912069B1
(de)
|
2012-10-23 |
2019-07-31 |
Emory University |
Gm-csf- und il-4-konjugate, zusammensetzungen und zugehörige verfahren
|
DK2988780T3
(en)
|
2013-04-25 |
2019-04-08 |
Janssen Vaccines & Prevention Bv |
STABILIZED SOLVEN RSV-F PREFUSION POLYPTIDES
|
WO2014179108A1
(en)
|
2013-05-03 |
2014-11-06 |
Honeywell International Inc. |
Lead frame construct for lead-free solder connections
|
EP3010931B1
(de)
|
2013-06-17 |
2018-06-13 |
Janssen Vaccines & Prevention B.V. |
Stabilisierte lösliche präfusionierte rsv-f-polypeptide
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
JP6466437B2
(ja)
*
|
2013-10-30 |
2019-02-06 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
微生物を複雑な試料から単離する方法
|
EP3122866B1
(de)
|
2014-03-25 |
2019-11-20 |
Terumo BCT, Inc. |
Passives ersetzen von medien
|
CN117402871A
(zh)
|
2014-04-25 |
2024-01-16 |
川斯勒佰尔公司 |
信使rna的纯化方法
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
CN105316296A
(zh)
*
|
2014-06-13 |
2016-02-10 |
亚宝药业太原制药有限公司 |
一种纯化腺病毒颗粒的方法
|
SG10201902168PA
(en)
|
2014-09-09 |
2019-04-29 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
CN107106689A
(zh)
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
US10597660B2
(en)
|
2014-11-14 |
2020-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
SG10202001102XA
(en)
|
2014-11-14 |
2020-03-30 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
EP3230441A4
(de)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Zusammensetzungen und verfahren zur herstellung von scaav
|
SG11201704919SA
(en)
|
2015-01-13 |
2017-07-28 |
Alfa Wassermann Inc |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav)
|
EP3054007A1
(de)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Reinigung von rekombinanten, adeno-assoziierten viren mit einem immunaffinen reinigungsschritt
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
AU2016249798B2
(en)
|
2015-04-14 |
2022-05-26 |
Janssen Vaccines And Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
BR112017028449A2
(pt)
|
2015-07-07 |
2018-09-04 |
Janssen Vaccines & Prevention Bv |
polipeptídeos rsv f pré-fusão solúveis estabilizados
|
CN116059336A
(zh)
|
2015-07-07 |
2023-05-05 |
扬森疫苗与预防公司 |
针对rsv的疫苗
|
US9663766B2
(en)
|
2015-07-24 |
2017-05-30 |
Bio-Rad Laboratories, Inc. |
Methods for purifying adenovirus vectors
|
IL258491B2
(en)
|
2015-10-16 |
2023-09-01 |
Univ Columbia |
Preparations and methods for inhibiting antigens of a particular lineage
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
EA201892250A1
(ru)
|
2016-04-05 |
2019-03-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
MA43763B1
(fr)
|
2016-04-05 |
2021-03-31 |
Janssen Vaccines & Prevention Bv |
Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs
|
CN116144500A
(zh)
*
|
2016-04-14 |
2023-05-23 |
崔泽尔有限公司 |
具有恒流泵/管道***的固定床生物反应器
|
CN109071594A
(zh)
*
|
2016-04-14 |
2018-12-21 |
崔泽尔有限公司 |
具有恒流泵/管道***的固定床生物反应器
|
US11299751B2
(en)
|
2016-04-29 |
2022-04-12 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
EP3448874A4
(de)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
Zusammensetzungen zur behandlung einer erkrankung
|
US20190134190A1
(en)
|
2016-05-04 |
2019-05-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
CN110214187B
(zh)
|
2016-05-18 |
2024-01-30 |
沃雅戈治疗公司 |
调节性多核苷酸
|
US11951121B2
(en)
|
2016-05-18 |
2024-04-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating Huntington's disease
|
WO2017205667A1
(en)
|
2016-05-25 |
2017-11-30 |
Terumo Bct, Inc. |
Cell expansion
|
CA3025441A1
(en)
|
2016-05-30 |
2017-12-07 |
Janssen Vaccines & Prevention B.V. |
Stabilized pre-fusion rsv f proteins
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
RU2745500C2
(ru)
|
2016-06-20 |
2021-03-25 |
Янссен Вэксинс Энд Превеншн Б.В. |
Эффективный и сбалансированный двунаправленный промотор
|
JP7229151B2
(ja)
|
2016-07-14 |
2023-02-27 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
Hpvワクチン
|
EP3831281A1
(de)
|
2016-08-30 |
2021-06-09 |
The Regents of The University of California |
Verfahren für biomedizinisches targeting und freisetzung sowie vorrichtungen und systeme zur ausführung davon
|
WO2018069316A2
(en)
|
2016-10-10 |
2018-04-19 |
Transgene Sa |
Immunotherapeutic product and mdsc modulator combination therapy
|
US20180119141A1
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Crispr/cas global regulator screening platform
|
US10294452B2
(en)
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
CN108085301B
(zh)
*
|
2016-11-22 |
2021-10-26 |
贺道耀 |
从宿主细胞提取和纯化腺相关病毒和腺病毒的方法及其组分和试剂盒
|
WO2018106888A1
(en)
*
|
2016-12-08 |
2018-06-14 |
Temple University-Of The Commonwealth System Of Higher Education |
Small animal models for in vivo testing of polyomavirus therapeutics
|
US20190345501A1
(en)
|
2017-02-07 |
2019-11-14 |
Massachusetts Institute Of Technology |
Methods and compositions for rna-guided genetic circuits
|
EP3601521A2
(de)
|
2017-03-31 |
2020-02-05 |
Terumo BCT, Inc. |
Zellexpansion
|
US11603542B2
(en)
|
2017-05-05 |
2023-03-14 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
CA3061368A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
EP3624844A1
(de)
|
2017-05-17 |
2020-03-25 |
Janssen Vaccines & Prevention B.V. |
Verfahren und zusammensetzungen zur induzierung schützender immunität gegen rsv-infektionen
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
EP3654860A1
(de)
|
2017-07-17 |
2020-05-27 |
Voyager Therapeutics, Inc. |
Trajektoriearrayführungssystem
|
EP3808849A1
(de)
|
2017-08-03 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Zusammensetzungen und verfahren zur aav-freisetzung
|
CN107384873A
(zh)
*
|
2017-09-05 |
2017-11-24 |
成都汇宇生物技术有限公司 |
重组腺病毒的纯化方法
|
BR112020004143A2
(pt)
|
2017-09-15 |
2020-09-01 |
Janssen Vaccines & Prevention B.V. |
método para a indução segura de imunidade contra vírus sincicial respiratório (rsv)
|
EP3697905A1
(de)
|
2017-10-16 |
2020-08-26 |
Voyager Therapeutics, Inc. |
Behandlung von amyotropher lateralsklerose (als)
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
CN111527202B
(zh)
*
|
2017-11-08 |
2024-03-29 |
蓝天免疫疗法有限责任公司 |
So3色谱在病毒纯化方法中的应用
|
EP3762500A1
(de)
|
2018-03-06 |
2021-01-13 |
Voyager Therapeutics, Inc. |
Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
|
JP2021521852A
(ja)
|
2018-04-27 |
2021-08-30 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
Aadcウイルスベクターの効力を測定する方法
|
CA3099306A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of parkinson's disease
|
EP3793616A1
(de)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Zusammensetzungen und verfahren zur aav-freisetzung
|
EP3793686A1
(de)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav-serotypen zur gehirnspezifischen payload-übertragung
|
US20210214749A1
(en)
|
2018-05-16 |
2021-07-15 |
Voyager Therapeutics, Inc. |
Directed evolution
|
WO2020010042A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
CN112638402A
(zh)
|
2018-07-03 |
2021-04-09 |
Sotio有限责任公司 |
与增强葡萄糖输入的反式代谢分子组合的嵌合受体及其治疗用途
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
JP2022520138A
(ja)
|
2018-08-28 |
2022-03-29 |
ブイオーアール バイオファーマ インコーポレーテッド |
遺伝子操作された造血幹細胞およびそれらの使用
|
JP2021534809A
(ja)
|
2018-10-02 |
2021-12-16 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics, Inc. |
Aavカプシドの向性の再指向化
|
EP3861113A1
(de)
|
2018-10-04 |
2021-08-11 |
Voyager Therapeutics, Inc. |
Verfahren zur messung des titers und der potenz von viralen vektorpartikeln
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
WO2020123524A1
(en)
*
|
2018-12-11 |
2020-06-18 |
Erbi Biosystems, Inc. |
Methods of manufacturing cell based products using small volume perfusion processes
|
TW202039858A
(zh)
|
2019-01-18 |
2020-11-01 |
美商航海家醫療公司 |
用於生產aav顆粒之方法及系統
|
US11542526B2
(en)
|
2019-02-21 |
2023-01-03 |
Unleash Immuno Oncolytics, Inc. |
Oncolytic adenoviral vector and methods of use
|
CN110093455B
(zh)
*
|
2019-04-27 |
2020-03-17 |
中国医学科学院病原生物学研究所 |
一种呼吸道病毒的检测方法
|
EP3962536A1
(de)
|
2019-04-29 |
2022-03-09 |
Voyager Therapeutics, Inc. |
Systeme und verfahren zur herstellung von baculovirusinfizierten insektenzellen (biics) in bioreaktoren
|
EP3966227A1
(de)
|
2019-05-07 |
2022-03-16 |
Voyager Therapeutics, Inc. |
Zusammensetzungen und verfahren zur vektorisierten vermehrung von proteinzerstörung, -expression und/oder -regulierung
|
CN112175996A
(zh)
*
|
2019-07-05 |
2021-01-05 |
杭州荣泽生物科技有限公司 |
一种基因治疗载体的制备方法和用途
|
US20220290182A1
(en)
|
2019-08-09 |
2022-09-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
EP4022070A1
(de)
|
2019-08-26 |
2022-07-06 |
Voyager Therapeutics, Inc. |
Kontrollierte expression viraler proteine
|
US20220333133A1
(en)
|
2019-09-03 |
2022-10-20 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
JP2023503259A
(ja)
*
|
2019-11-15 |
2023-01-27 |
シティ・オブ・ホープ |
アデノ随伴ウイルスの増強された生産のための高密度細胞呼吸器を含むバイオプロダクトの生産のためのシステム、デバイスおよび方法
|
CN110894494B
(zh)
*
|
2019-11-22 |
2022-09-27 |
广西梧州制药(集团)股份有限公司 |
一种大规模高密度悬浮培养293细胞高产腺病毒的方法
|
WO2021202651A1
(en)
|
2020-04-01 |
2021-10-07 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
WO2021211753A1
(en)
|
2020-04-15 |
2021-10-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
GB202005732D0
(en)
|
2020-04-20 |
2020-06-03 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
TW202208397A
(zh)
|
2020-05-13 |
2022-03-01 |
美商航海家醫療公司 |
Aav蛋白殼之趨性重定向
|
EP4192514A1
(de)
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
CN112226418B
(zh)
*
|
2020-09-25 |
2022-07-08 |
阜外华中心血管病医院 |
重组腺相关病毒纯化方法
|
CA3195177A1
(en)
|
2020-10-07 |
2022-04-14 |
Asklepios Biopharmaceutical, Inc. |
Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i)
|
CN112293394B
(zh)
*
|
2020-10-30 |
2022-11-25 |
海南德安欣有害生物防治科技有限公司 |
一种捕鼠装置及捕鼠方法
|
US20230407328A1
(en)
|
2020-11-02 |
2023-12-21 |
Biomarin Pharmaceutical Inc. |
Process for enriching adeno-associated virus
|
GB202019454D0
(en)
*
|
2020-12-10 |
2021-01-27 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Method for purifying virus
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
JP2024515626A
(ja)
|
2021-04-16 |
2024-04-10 |
アスクレピオス バイオファーマシューティカル, インコーポレイテッド |
血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドaavビリオン
|
EP4396203A1
(de)
|
2021-09-03 |
2024-07-10 |
BioMarin Pharmaceutical Inc. |
Aav-kapsid-zusammensetzungen und verfahren zur freisetzung
|
WO2023034997A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
WO2023034994A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
WO2023034980A1
(en)
|
2021-09-03 |
2023-03-09 |
Bomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
EP4396202A1
(de)
|
2021-09-03 |
2024-07-10 |
BioMarin Pharmaceutical Inc. |
Aav-kapsid-zusammensetzungen und verfahren zur freisetzung
|
WO2023034990A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
WO2023044483A2
(en)
|
2021-09-20 |
2023-03-23 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
EP4408982A1
(de)
|
2021-09-27 |
2024-08-07 |
SOTIO Biotech Inc. |
Chimäre rezeptorpolypeptide in kombination mit transmetabolismusmolekülen zur neuausrichtung von glucosemetaboliten aus dem glykolyseweg und therapeutische verwendungen davon
|
IL311861A
(en)
|
2021-11-02 |
2024-06-01 |
Voyager Therapeutics Inc |
Adeno-associated virus capsid variants and their uses
|
WO2023091909A1
(en)
|
2021-11-16 |
2023-05-25 |
Sotio Biotech Inc. |
Treatment of myxoid/round cell liposarcoma patients
|
WO2023091948A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
CA3240342A1
(en)
|
2021-12-16 |
2023-06-22 |
Gopal SAPKOTA |
Targeted degradation of alpha-synuclein
|
WO2023147374A2
(en)
|
2022-01-25 |
2023-08-03 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
WO2023154693A1
(en)
|
2022-02-08 |
2023-08-17 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
GB202201713D0
(en)
|
2022-02-10 |
2022-03-30 |
Univ Dundee |
An affinity directed phosphatase system for targeted protein dephosphorylation
|
CN115354033A
(zh)
*
|
2022-03-25 |
2022-11-18 |
上海碧博生物医药科技有限公司 |
一种细胞裂解液、细胞裂解方法及该方法在收获aav的应用
|
WO2023235791A1
(en)
|
2022-06-02 |
2023-12-07 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
TW202417467A
(zh)
|
2022-06-28 |
2024-05-01 |
美商航海家醫療公司 |
Aav蛋白殼變異體及其用途
|
WO2024011112A1
(en)
|
2022-07-06 |
2024-01-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2024040207A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
|
WO2024040208A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2024059739A1
(en)
|
2022-09-15 |
2024-03-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
TW202417631A
(zh)
|
2022-09-22 |
2024-05-01 |
美商拜奧馬林製藥公司 |
用aav基因治療載體治療心肌病
|
WO2024064863A2
(en)
|
2022-09-22 |
2024-03-28 |
Biomarin Pharmaceutical Inc. |
Treatment of arrhythmogenic cardiomyopathy with aav gene therapy vectors
|
CN117551624A
(zh)
*
|
2024-01-11 |
2024-02-13 |
深圳源兴基因技术有限公司 |
一种基于无血清悬浮扩增的高效回收腺病毒的方法
|